endo-BCN-Fmoc-L-Lysine>95.0%(HPLC)25mg

4-Amino-3-(3-fluorophenyl)-1H-1,2,4-triazole-5(4H)-thione, 95%, 2.5g

Bosutinib, 99%, 10mg

2-Methoxyisobutyronitrile, 5g

3-ethoxy-4-[(2-methyl-2-propen-1-yl)oxy]benzaldehyde, 95.0%, 1g

2-Ethoxy-5-pyridineboronic acid, 95.0%, 100g

Diethoxydimethylsilane>98.0%(GC)25mL

1-(1-piperidinylsulfonyl)-1,4-diazepane, 95.0%, 5g

Methyl6-cyano-4-methyl-pyridine-3-carboxylate, 98%, 100mg

tert-Butyl N-(1-cyanocyclopentyl)carbamate, 95%, 10g

3',6'-Bis(dimethylamino)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid, 98%, 1g

5-Bromo-6-methoxy-1,3-dihydropyrrolo[2,3-b]pyridin-2-one, 98%, 100mg

Benzyl 7-Oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate>97.0%(GC)200mg